Indonesia’s Minister of Health, Budi Gunadi Sadikin, has emphatically rejected the notion that Indonesia is being used as a “guinea pig” in the development of a tuberculosis (TB) vaccine. He emphasized the country’s pivotal role in fighting this deadly infectious disease and warned against spreading misinformation that could discourage vaccination efforts, potentially leading to the loss of 100,000 lives. Minister Budi underscored the successful rollout of COVID-19 vaccination programs in combating the pandemic and called on media professionals to combat falsehoods that could hinder vaccination rates. The TB vaccine currently undergoing Phase 3 clinical trials in Indonesia is the product of extensive research conducted by local universities, with more than 2,000 participants closely monitored during the trials. Minister Budi stressed the importance of adhering to scientific protocols in vaccine development and highlighted the life-saving historical impact of vaccines. Tuberculosis remains a significant global health challenge, claiming over one million lives each year, with approximately 125,000 deaths occurring in Indonesia. By participating in the vaccine trials, Indonesia is also aiming to establish local vaccine manufacturing capabilities and potentially become a pivotal hub for production. Minister Budi addressed concerns about the vaccine’s suitability for Indonesians, emphasizing the critical role of local involvement in the trials. He dispelled rumors surrounding the location of a vaccine factory and outlined the government’s strategy to integrate the TB vaccine into the national immunization program. The Minister concluded by underscoring the severity of TB as an infectious disease and the urgent need for comprehensive vaccination initiatives.
Share
- Advertisement -
Baca Lainnya
